📰 Accustem News
Page 2 - Accustem News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Accustem. Real-time updates on events, politics, business and more.
March 23, 2022
LONDON and PHOENIX, March 23, 2022 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTC Pink: ACUT), a life sciences company dedicated to improving outcomes for patients with cancer, is pleased to announce
March 23, 2022
Company plans to uplist to the Nasdaq Capital MarketLONDON and PHOENIX, March 04, 2022 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTC PINK: ACUT), a life sciences company dedicated to improving outcomes
March 4, 2022
Company plans to uplist to the Nasdaq Capital MarketLONDON and PHOENIX, March 04, 2022 -- AccuStem Sciences, Inc. , a life sciences company dedicated to improving outcomes for patients with cancer,... | March 4, 2022
March 4, 2022
Company plans to uplist to the Nasdaq Capital MarketLONDON and PHOENIX, March 04, 2022 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTC PINK: ACUT), a life sciences company dedicated to improving outcomes
March 1, 2022
New York, March 1, 2022 - Tiziana Life Sciences Ltd. reports that its former subsidiary, AccuStem Sciences, Inc. , today announced publication of new data in the European Journal of Cancer.... | March 1, 2022
March 1, 2022
LONDON and PHOENIX, March 01, 2022 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTC PINK: ACMSY), a life sciences company dedicated to improving outcomes for patients with cancer, today announced publication
December 1, 2021
SCHEME OF ARRANGEMENT EFFECTIVE LONDON, Dec. 01, 2021 (GLOBE NEWSWIRE) -- ACCUSTEM UK is pleased to announce that, further to the announcement dated 30 November 2021 that the Court has sanctioned the
April 13, 2021
(0) NEW YORK and LONDON, April 13, 2021 (GLOBE NEWSWIRE) -- Tiziana Life Sciences plc (NASDAQ:TLSA; LSE: TILS), today announced that its former subsidiary, Accustem Sciences Limited ("Accustem"), intends to file a listing application with the Nasdaq Stock Market shortly after completion of the distribution of shares in Accustem to Tiziana Life Sciences plc shareholders. The board of directors of Accustem has resolved that the Nasdaq listing venue is more appropriate to the nature of Accustems b...